Status:
COMPLETED
MyVoice:Rheum Decision Aid for Women With Rheumatic Diseases
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions:
Rheumatic Diseases
Physician-Patient Relations
Eligibility:
FEMALE
18-44 years
Phase:
NA
Brief Summary
This is a pilot trial to assess feasibility and acceptability of MyVoice:Rheum vs. a patient pamphlet among female patients ages 18-44 (n=40) who receive rheumatology care. • Hypothesis: MyVoice:Rheu...
Detailed Description
The pilot will demonstrate if the MyVoice:Rheum decision aid can be feasibly and acceptably implemented into the rheumatology context and inform operational procedures for a future hybrid effectivenes...
Eligibility Criteria
Inclusion
- Patients must have at least one of four rheumatic diseases diagnosed by a rheumatologist: rheumatoid arthritis (RA), systemic sclerosis (SSc), myositis, Sjogren's syndrome, vasculitis, spondyloarthritis, and systemic lupus erythematosus (SLE).
- Patients must read and speak in English as a Spanish-language version of the tool has not yet been developed
- Access to a smart phone, personal computer, or tablet.
Exclusion
- Women who have had prior hysterectomy or sterilization, or are pregnant.
Key Trial Info
Start Date :
July 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2023
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04879745
Start Date
July 29 2021
End Date
March 1 2023
Last Update
April 30 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
UPMC Falk Rheumatology Clinic
Pittsburgh, Pennsylvania, United States, 15213
2
UPMC Lupus Center of Excellence
Pittsburgh, Pennsylvania, United States, 15213